世界のオピオイド誘発性便秘市場：専門的調査

• 英文タイトル：Global Opioid-Induced Constipation Market Professional Survey Report 2019

• レポートコード：QYR9ST14119
• 出版社/出版日：QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、119ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥518,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,036,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※本調査レポートは、オピオイド誘発性便秘の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、臭化メチルナルトレキソン、ルビプロストン、ナロキセゴール、その他に、用途別には、病院、薬局にセグメント区分し、オピオイド誘発性便秘の世界市場を分析しました。

・エグゼクティブ・サマリー
・オピオイド誘発性便秘の世界市場概要
・オピオイド誘発性便秘の製造コスト構成分析
・オピオイド誘発性便秘の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・オピオイド誘発性便秘の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・オピオイド誘発性便秘のセグメント分析（種類別）
（臭化メチルナルトレキソン、ルビプロストン、ナロキセゴール、その他）
・オピオイド誘発性便秘のセグメント分析（用途別）
（病院、薬局）
・オピオイド誘発性便秘の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Takeda Pharmaceuticals、Bayer、Sanofi、Mallinckrodt、Salix (Bausch Health)、AstraZeneca、Progenics Pharmaceuticals、Purdue Pharm、Nektar Therapeutics、Daiichi Sankyo、Prestige、GSK、Shionogi）
・オピオイド誘発性便秘の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.In the last several years, global market of Opioid-Induced Constipation developed smoothly, with an average growth rate of 3.85% from the forecast period 2019 to 2025.
The classification of Opioid-Induced Constipation includes Methylnaltrexone Bromide, Lubiprostone, Naloxegol and other OTC drugs. The revenue proportion of Lubiprostone in 2017 is about 33%, and the proportion of OTC drugs is in about 34%.
Opioid-Induced Constipation is widely sold in Hospital, Pharmacy and other field. The most proportion of Opioid-Induced Constipation is sold in Pharmacy, and the proportion in 2017 is 45.99%.

The global Opioid-Induced Constipation market was valued at 2240 million US$ in 2018 and will reach 3060 million US$ by the end of 2025, growing at a CAGR of 4.6% during 2019-2025.
This report focuses on Opioid-Induced Constipation volume and value at global level, regional level and company level. From a global perspective, this report represents overall Opioid-Induced Constipation market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Opioid-Induced Constipation in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Opioid-Induced Constipation manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Takeda Pharmaceuticals
Bayer
Sanofi
Mallinckrodt
Salix (Bausch Health)
AstraZeneca
Progenics Pharmaceuticals
Purdue Pharm
Nektar Therapeutics
Daiichi Sankyo
Prestige
GSK
Shionogi

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others

Segment by Application
Hospital
Pharmacy

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Opioid-Induced Constipation
1.1 Definition of Opioid-Induced Constipation
1.2 Opioid-Induced Constipation Segment by Type
1.2.1 Global Opioid-Induced Constipation Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Opioid-Induced Constipation Segment by Applications
1.3.1 Global Opioid-Induced Constipation Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Opioid-Induced Constipation Overall Market
1.4.1 Global Opioid-Induced Constipation Revenue (2014-2025)
1.4.2 Global Opioid-Induced Constipation Production (2014-2025)
1.4.3 North America Opioid-Induced Constipation Status and Prospect (2014-2025)
1.4.4 Europe Opioid-Induced Constipation Status and Prospect (2014-2025)
1.4.5 China Opioid-Induced Constipation Status and Prospect (2014-2025)
1.4.6 Japan Opioid-Induced Constipation Status and Prospect (2014-2025)
1.4.7 Southeast Asia Opioid-Induced Constipation Status and Prospect (2014-2025)
1.4.8 India Opioid-Induced Constipation Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Opioid-Induced Constipation
2.3 Manufacturing Process Analysis of Opioid-Induced Constipation
2.4 Industry Chain Structure of Opioid-Induced Constipation

3 Development and Manufacturing Plants Analysis of Opioid-Induced Constipation
3.1 Capacity and Commercial Production Date
3.2 Global Opioid-Induced Constipation Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Opioid-Induced Constipation
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Opioid-Induced Constipation Production and Capacity Analysis
4.2 Opioid-Induced Constipation Revenue Analysis
4.3 Opioid-Induced Constipation Price Analysis
4.4 Market Concentration Degree

5 Opioid-Induced Constipation Regional Market Analysis
5.1 Opioid-Induced Constipation Production by Regions
5.1.1 Global Opioid-Induced Constipation Production by Regions
5.1.2 Global Opioid-Induced Constipation Revenue by Regions
5.2 Opioid-Induced Constipation Consumption by Regions
5.3 North America Opioid-Induced Constipation Market Analysis
5.3.1 North America Opioid-Induced Constipation Production
5.3.2 North America Opioid-Induced Constipation Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Opioid-Induced Constipation Import and Export
5.4 Europe Opioid-Induced Constipation Market Analysis
5.4.1 Europe Opioid-Induced Constipation Production
5.4.2 Europe Opioid-Induced Constipation Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Opioid-Induced Constipation Import and Export
5.5 China Opioid-Induced Constipation Market Analysis
5.5.1 China Opioid-Induced Constipation Production
5.5.2 China Opioid-Induced Constipation Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Opioid-Induced Constipation Import and Export
5.6 Japan Opioid-Induced Constipation Market Analysis
5.6.1 Japan Opioid-Induced Constipation Production
5.6.2 Japan Opioid-Induced Constipation Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Opioid-Induced Constipation Import and Export
5.7 Southeast Asia Opioid-Induced Constipation Market Analysis
5.7.1 Southeast Asia Opioid-Induced Constipation Production
5.7.2 Southeast Asia Opioid-Induced Constipation Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Opioid-Induced Constipation Import and Export
5.8 India Opioid-Induced Constipation Market Analysis
5.8.1 India Opioid-Induced Constipation Production
5.8.2 India Opioid-Induced Constipation Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Opioid-Induced Constipation Import and Export

6 Opioid-Induced Constipation Segment Market Analysis (by Type)
6.1 Global Opioid-Induced Constipation Production by Type
6.2 Global Opioid-Induced Constipation Revenue by Type
6.3 Opioid-Induced Constipation Price by Type

7 Opioid-Induced Constipation Segment Market Analysis (by Application)
7.1 Global Opioid-Induced Constipation Consumption by Application
7.2 Global Opioid-Induced Constipation Consumption Market Share by Application (2014-2019)

8 Opioid-Induced Constipation Major Manufacturers Analysis
8.1 Takeda Pharmaceuticals
8.1.1 Takeda Pharmaceuticals Opioid-Induced Constipation Production Sites and Area Served
8.1.2 Takeda Pharmaceuticals Product Introduction, Application and Specification
8.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer
8.2.1 Bayer Opioid-Induced Constipation Production Sites and Area Served
8.2.2 Bayer Product Introduction, Application and Specification
8.2.3 Bayer Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Sanofi
8.3.1 Sanofi Opioid-Induced Constipation Production Sites and Area Served
8.3.2 Sanofi Product Introduction, Application and Specification
8.3.3 Sanofi Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Mallinckrodt
8.4.1 Mallinckrodt Opioid-Induced Constipation Production Sites and Area Served
8.4.2 Mallinckrodt Product Introduction, Application and Specification
8.4.3 Mallinckrodt Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Salix (Bausch Health)
8.5.1 Salix (Bausch Health) Opioid-Induced Constipation Production Sites and Area Served
8.5.2 Salix (Bausch Health) Product Introduction, Application and Specification
8.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 AstraZeneca
8.6.1 AstraZeneca Opioid-Induced Constipation Production Sites and Area Served
8.6.2 AstraZeneca Product Introduction, Application and Specification
8.6.3 AstraZeneca Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Progenics Pharmaceuticals
8.7.1 Progenics Pharmaceuticals Opioid-Induced Constipation Production Sites and Area Served
8.7.2 Progenics Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Purdue Pharm
8.8.1 Purdue Pharm Opioid-Induced Constipation Production Sites and Area Served
8.8.2 Purdue Pharm Product Introduction, Application and Specification
8.8.3 Purdue Pharm Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Nektar Therapeutics
8.9.1 Nektar Therapeutics Opioid-Induced Constipation Production Sites and Area Served
8.9.2 Nektar Therapeutics Product Introduction, Application and Specification
8.9.3 Nektar Therapeutics Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Daiichi Sankyo
8.10.1 Daiichi Sankyo Opioid-Induced Constipation Production Sites and Area Served
8.10.2 Daiichi Sankyo Product Introduction, Application and Specification
8.10.3 Daiichi Sankyo Opioid-Induced Constipation Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Prestige
8.12 GSK
8.13 Shionogi

9 Development Trend of Analysis of Opioid-Induced Constipation Market
9.1 Global Opioid-Induced Constipation Market Trend Analysis
9.1.1 Global Opioid-Induced Constipation Market Size (Volume and Value) Forecast 2019-2025
9.2 Opioid-Induced Constipation Regional Market Trend
9.2.1 North America Opioid-Induced Constipation Forecast 2019-2025
9.2.2 Europe Opioid-Induced Constipation Forecast 2019-2025
9.2.3 China Opioid-Induced Constipation Forecast 2019-2025
9.2.4 Japan Opioid-Induced Constipation Forecast 2019-2025
9.2.5 Southeast Asia Opioid-Induced Constipation Forecast 2019-2025
9.2.6 India Opioid-Induced Constipation Forecast 2019-2025
9.3 Opioid-Induced Constipation Market Trend (Product Type)
9.4 Opioid-Induced Constipation Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Opioid-Induced Constipation Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Opioid-Induced Constipation
Table Global Opioid-Induced Constipation Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Opioid-Induced Constipation Production Market Share by Types in 2018
Figure Methylnaltrexone Bromide Product Picture
Figure Lubiprostone Product Picture
Figure Naloxegol Product Picture
Figure Others Product Picture
Table Global Opioid-Induced Constipation Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Opioid-Induced Constipation Consumption Market Share by Applications in 2018
Figure Hospital
Figure Pharmacy
Figure Global Opioid-Induced Constipation Revenue (Million USD) (2014-2025)
Figure Global Opioid-Induced Constipation Production (K Units) (2014-2025)
Figure North America Opioid-Induced Constipation Market Size (Million USD) (2014-2025)
Figure Europe Opioid-Induced Constipation Market Size (Million USD) (2014-2025)
Figure China Opioid-Induced Constipation Market Size (Million USD) (2014-2025)
Figure Japan Opioid-Induced Constipation Market Size (Million USD) (2014-2025)
Figure Southeast Asia Opioid-Induced Constipation Market Size (Million USD) (2014-2025)
Figure India Opioid-Induced Constipation Market Size (Million USD) (2014-2025)
Table Opioid-Induced Constipation Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Opioid-Induced Constipation in 2018
Figure Manufacturing Process Analysis of Opioid-Induced Constipation
Figure Industry Chain Structure of Opioid-Induced Constipation
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Opioid-Induced Constipation Manufacturing Plants Distribution
Table Opioid-Induced Constipation Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Opioid-Induced Constipation Capacity (K Units) of Major Manufacturers (2014-2019)
Table Opioid-Induced Constipation Production (K Units) of Major Manufacturers (2014-2019)
Table Opioid-Induced Constipation Production Market Share of Major Manufacturers (2014-2019)
Figure Opioid-Induced Constipation Production Share by Manufacturers in 2018
Table Opioid-Induced Constipation Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Opioid-Induced Constipation Revenue Market Share of Major Manufacturers (2014-2019)
Figure Opioid-Induced Constipation Revenue Share by Manufacturers in 2018
Table Opioid-Induced Constipation Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Opioid-Induced Constipation Production by Regions 2014-2019 (K Units)
Table Global Opioid-Induced Constipation Production Market Share by Regions 2014-2019
Figure Global Opioid-Induced Constipation Production Market Share by Regions in 2018
Table Global Opioid-Induced Constipation Revenue by Regions 2014-2019 (Million USD)
Table Global Opioid-Induced Constipation Revenue Market Share by Regions 2014-2019
Figure Global Opioid-Induced Constipation Revenue Market Share by Regions in 2018
Table Global Opioid-Induced Constipation Consumption by Regions 2014-2019 (K Units)
Table Global Opioid-Induced Constipation Consumption Market Share by Regions 2014-2019
Figure North America Opioid-Induced Constipation Production Growth Rate 2014-2019 (K Units)
Figure North America Opioid-Induced Constipation Revenue Growth Rate 2014-2019 (Million USD)
Table North America Opioid-Induced Constipation Production, Consumption Import and Export (K Units)
Figure Europe Opioid-Induced Constipation Production Growth Rate 2014-2019 (K Units)
Figure Europe Opioid-Induced Constipation Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Opioid-Induced Constipation Production, Consumption Import and Export (K Units)
Figure China Opioid-Induced Constipation Production Growth Rate 2014-2019 (K Units)
Figure China Opioid-Induced Constipation Revenue Growth Rate 2014-2019 (Million USD)
Table China Opioid-Induced Constipation Production, Consumption Import and Export (K Units)
Figure Japan Opioid-Induced Constipation Production Growth Rate 2014-2019 (K Units)
Figure Japan Opioid-Induced Constipation Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Opioid-Induced Constipation Production, Consumption Import and Export (K Units)
Figure Southeast Asia Opioid-Induced Constipation Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Opioid-Induced Constipation Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Opioid-Induced Constipation Production, Consumption Import and Export (K Units)
Figure India Opioid-Induced Constipation Production Growth Rate 2014-2019 (K Units)
Figure India Opioid-Induced Constipation Revenue Growth Rate 2014-2019 (Million USD)
Table India Opioid-Induced Constipation Production, Consumption Import and Export (K Units)
Figure Global Consumption Opioid-Induced Constipation Market Share by Application (2014-2019)
Figure Global Value (Consumption) Opioid-Induced Constipation Market Share by Application (2014-2019)
Table Takeda Pharmaceuticals Opioid-Induced Constipation Production Sites and Area Served
Table Takeda Pharmaceuticals Opioid-Induced Constipation Product Introduction, Application and Specification
Table Takeda Pharmaceuticals Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceuticals Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Takeda Pharmaceuticals Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Takeda Pharmaceuticals Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Takeda Pharmaceuticals Opioid-Induced Constipation Main Business and Markets Served
Table Bayer Opioid-Induced Constipation Production Sites and Area Served
Table Bayer Opioid-Induced Constipation Product Introduction, Application and Specification
Table Bayer Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Bayer Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Bayer Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Bayer Opioid-Induced Constipation Main Business and Markets Served
Table Sanofi Opioid-Induced Constipation Production Sites and Area Served
Table Sanofi Opioid-Induced Constipation Product Introduction, Application and Specification
Table Sanofi Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Sanofi Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Sanofi Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Sanofi Opioid-Induced Constipation Main Business and Markets Served
Table Mallinckrodt Opioid-Induced Constipation Production Sites and Area Served
Table Mallinckrodt Opioid-Induced Constipation Product Introduction, Application and Specification
Table Mallinckrodt Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Mallinckrodt Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Mallinckrodt Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Mallinckrodt Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Mallinckrodt Opioid-Induced Constipation Main Business and Markets Served
Table Salix (Bausch Health) Opioid-Induced Constipation Production Sites and Area Served
Table Salix (Bausch Health) Opioid-Induced Constipation Product Introduction, Application and Specification
Table Salix (Bausch Health) Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Salix (Bausch Health) Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Salix (Bausch Health) Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Salix (Bausch Health) Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Salix (Bausch Health) Opioid-Induced Constipation Main Business and Markets Served
Table AstraZeneca Opioid-Induced Constipation Production Sites and Area Served
Table AstraZeneca Opioid-Induced Constipation Product Introduction, Application and Specification
Table AstraZeneca Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table AstraZeneca Opioid-Induced Constipation Production Market Share (2014-2019)
Figure AstraZeneca Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table AstraZeneca Opioid-Induced Constipation Main Business and Markets Served
Table Progenics Pharmaceuticals Opioid-Induced Constipation Production Sites and Area Served
Table Progenics Pharmaceuticals Opioid-Induced Constipation Product Introduction, Application and Specification
Table Progenics Pharmaceuticals Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Progenics Pharmaceuticals Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Progenics Pharmaceuticals Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Progenics Pharmaceuticals Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Progenics Pharmaceuticals Opioid-Induced Constipation Main Business and Markets Served
Table Purdue Pharm Opioid-Induced Constipation Production Sites and Area Served
Table Purdue Pharm Opioid-Induced Constipation Product Introduction, Application and Specification
Table Purdue Pharm Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Purdue Pharm Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Purdue Pharm Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Purdue Pharm Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Purdue Pharm Opioid-Induced Constipation Main Business and Markets Served
Table Nektar Therapeutics Opioid-Induced Constipation Production Sites and Area Served
Table Nektar Therapeutics Opioid-Induced Constipation Product Introduction, Application and Specification
Table Nektar Therapeutics Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Nektar Therapeutics Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Nektar Therapeutics Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Nektar Therapeutics Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Nektar Therapeutics Opioid-Induced Constipation Main Business and Markets Served
Table Daiichi Sankyo Opioid-Induced Constipation Production Sites and Area Served
Table Daiichi Sankyo Opioid-Induced Constipation Product Introduction, Application and Specification
Table Daiichi Sankyo Opioid-Induced Constipation Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Daiichi Sankyo Opioid-Induced Constipation Production Growth Rate (2014-2019)
Table Daiichi Sankyo Opioid-Induced Constipation Production Market Share (2014-2019)
Figure Daiichi Sankyo Opioid-Induced Constipation Revenue Market Share (2014-2019)
Table Daiichi Sankyo Opioid-Induced Constipation Main Business and Markets Served
Table Prestige Opioid-Induced Constipation Production Sites and Area Served
Table GSK Opioid-Induced Constipation Production Sites and Area Served
Table Shionogi Opioid-Induced Constipation Production Sites and Area Served
Figure Global Opioid-Induced Constipation Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Opioid-Induced Constipation Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Opioid-Induced Constipation Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Opioid-Induced Constipation Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Opioid-Induced Constipation Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Opioid-Induced Constipation Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Opioid-Induced Constipation Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Opioid-Induced Constipation Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Opioid-Induced Constipation Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Opioid-Induced Constipation Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Opioid-Induced Constipation Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Opioid-Induced Constipation Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Opioid-Induced Constipation Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Opioid-Induced Constipation Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Opioid-Induced Constipation Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Opioid-Induced Constipation by Type (2019-2025)
Table Global Consumption (K Units) of Opioid-Induced Constipation by Application (2019-2025)
Table Opioid-Induced Constipation Distributors List
Table Opioid-Induced Constipation Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

オピオイド使用障害の世界市場：市場規模・現状・予測

Global Opioid Use Disorder Market Size, Status and Forecast 2019-2025
QYR9ST14561 2019年9月10日 97Pages
※当調査レポートでは、オピオイド使用障害の世界市場について調査・分析し、オピオイド使用障害の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（ブプレノルフィン、メタドン、ナルトレキソン）、用途別（中等度...

世界の化学療法による脱毛用頭皮クールデバイス市場：専門的調査

Global Scalp Cool Devices for Chemotherapy Induced Hair Loss Market Professional Survey Report 2019
QYR9ST05634 2019年9月2日 100Pages
※本調査レポートは、化学療法による脱毛用頭皮クールデバイスの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、頭皮クールキャップ、頭皮クールシステムに、用途別には...

世界の化学療法による脱毛用頭皮クールデバイス市場：専門的調査

世界の化学療法による吐き気・嘔吐（CINV）治療薬市場：専門的調査

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Professional Survey Report 2019
QYR9ST05901 2019年9月2日 102Pages
※本調査レポートは、化学療法による吐き気・嘔吐（CINV）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、5-HT3阻害剤、NK1阻害剤、その他に、用途...

世界の化学療法による吐き気・嘔吐（CINV）治療薬市場：専門的調査

胃腸障害治療薬の世界市場：市場規模・現状・予測

Global Gastrointestinal Disorder Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST04164 2019年9月2日 99Pages
※当調査レポートでは、胃腸障害治療薬の世界市場について調査・分析し、胃腸障害治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（過敏性腸症候群（IBS）、慢性便秘（CC）、潰瘍性大腸炎（UC））、...

神経障害性疼痛管理の世界市場：市場規模・現状・予測

Global Neuropathic Pain Management Market Size, Status and Forecast 2019-2025
QYR9ST09570 2019年9月5日 93Pages
※当調査レポートでは、神経障害性疼痛管理の世界市場について調査・分析し、神経障害性疼痛管理の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（三環系抗うつ薬、抗痙攣薬、オピオイド、ステロイド薬、局所麻酔...

頭皮冷却装置の世界市場：市場規模・現状・予測

Global Scalp Cooling Systems Market Size, Status and Forecast 2019-2025
QYR9ST04538 2019年9月2日 92Pages
※当調査レポートでは、頭皮冷却装置の世界市場について調査・分析し、頭皮冷却装置の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法による脱毛、新生児脳症、心停止、その他）、用途別（病院、クリニッ...

職業医学の世界市場：市場規模・現状・予測

Global Occupational Medicine Market Size, Status and Forecast 2019-2025
QYR9ST04982 2019年9月2日 99Pages
※当調査レポートでは、職業医学の世界市場について調査・分析し、職業医学の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（仕事によるストレス、石綿肺、騒音による難聴、仕事関連の腰痛、化学物質及び振動によ...

がん支持療法の世界市場：インサイト・予測

Global Cancer Supportive Care Market Insights, Forecast to 2025
QYR9ST02348 2019年9月2日 119Pages
※本調査レポートでは、世界のがん支持療法市場について調査・分析し、以下の構成でお届け致します。がん支持療法の種類別には、非ステロイド性エリスロポエチン刺激剤、オピオイド鎮痛薬、抗炎症薬、抗感染薬、ビスホスホネート、制吐薬、モノクローナル抗体、顆粒球コロニー刺激因子に、用途別には、肺がん、乳がん、前立...

オピオイド使用障害の世界市場：市場規模・現状・予測 An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.Increase in opioid epidemic in the U.S. coupled with establishment of government polic…
世界の化学療法による脱毛用頭皮クールデバイス市場：専門的調査 The global Scalp Cool Devices for Chemotherapy Induced Hair Loss market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Scalp Cool Devices for Chemotherapy Induced Hair Loss volume and value at g…
世界の化学療法による脱毛用頭皮クールデバイス市場：専門的調査 The global Scalp Cool Devices for Chemotherapy Induced Hair Loss market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Scalp Cool Devices for Chemotherapy Induced Hair Loss volume and value at g…
世界の化学療法による吐き気・嘔吐（CINV）治療薬市場：専門的調査 Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs i…
世界の化学療法による吐き気・嘔吐（CINV）治療薬市場：専門的調査 Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families.The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs i…